Please use this identifier to cite or link to this item: https://doi.org/10.1517/17425247.2013.729576
Title: Theranostic liposomes for cancer diagnosis and treatment: Current development and pre-clinical success
Authors: Muthu, M.S.
Feng, S.-S. 
Keywords: Cancer chemotherapy
Diagnosis
Folate targeting
Nanotheranostics
Quantum dots
Stealth liposomes
Vitamin E TPGS
Issue Date: Feb-2013
Source: Muthu, M.S., Feng, S.-S. (2013-02). Theranostic liposomes for cancer diagnosis and treatment: Current development and pre-clinical success. Expert Opinion on Drug Delivery 10 (2) : 151-155. ScholarBank@NUS Repository. https://doi.org/10.1517/17425247.2013.729576
Abstract: Liposomes are one of the effective drug delivery systems that are developed based on the nanotechnology concept. Liposomal formulation is the first nanomedicine approved by the US FDA for clinical application. Recently, the marketed liposomes and stealth liposomes have made impact for cancer therapy. In addition, a few receptor-targeted liposome products have been in different phases of clinical trials, which are yet to be marketed. In the present editorial, the advantages of vitamin E TPGS-coated liposomes over the currently available PEG-coated liposomes will be described and their great potentials for nanotheranostics for cancer imaging and therapy will be covered. © 2013 Informa UK, Ltd.
Source Title: Expert Opinion on Drug Delivery
URI: http://scholarbank.nus.edu.sg/handle/10635/68446
ISSN: 17425247
DOI: 10.1517/17425247.2013.729576
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

40
checked on Dec 14, 2017

WEB OF SCIENCETM
Citations

35
checked on Nov 19, 2017

Page view(s)

26
checked on Dec 17, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.